The trial’s primary efficacy endpoint is AF burden, which refers to the percentage of time a participant is in AF.
Doctors at Columbus Community Hospital now have a high-tech new tool that can help them diagnose irregular heart rhythms that may not show up during standard testing. The tool, called a cardiac loop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback